Mirjana
Mirjana Banjevic, Lausanne CH
Patent application number | Description | Published |
---|---|---|
20110101975 | MAGNETIC FIELD SENSOR MEASURING A DIRECTION OF A MAGNETIC FIELD IN A PLANE AND CURRENT SENSOR - A magnetic field sensor for measuring a direction of a magnetic field in a plane comprises two sensing structures ( | 05-05-2011 |
Mirjana Bukvic-Krajacic, Zagreb HR
Patent application number | Description | Published |
---|---|---|
20080200404 | Novel Antimalarial 9A-Carbamoyl-Aminoalkyl and 9A-Thiocarbamoyl-Aminoalkyl Azalides - Novel 9a-N′-substituted-carbamoyl- and thiocarbamoyl-aminoalkyl-9a-aza-9-deoxo-9-dihydro-9a-homoerythromycin A and 3-O-decladinosyl-9a-aza-9-deoxo-9-dihydro-9a-homoerythromycin A compounds having antimalarial activity are claimed. More particularly, the invention relates to 9a-N′-substituted-carbamoyl- and thiocarbamoyl-β-aminoethyl- or -γ-aminopropyl-9a-aza-9-deoxo-9-dihydro-9a-homoerythromycin A and 3-O-decladinosyl-9a-aza-9-deoxo-9-dihydro-9a-homoerythromycin A compounds and to pharmaceutically acceptable derivatives thereof having antimalarial activity. | 08-21-2008 |
20110039795 | 2'-O,3'-N-BRIDGED MACROLIDES - Novel 2′-O,3′-N-bridged macrolides useful in treatment of inflammatory diseases. More particularly, the invention relates to 2′-O,3′-N-bridged 14-membered macrolides and to 2′-O,3′-N-bridged 15-membered azalide macrolides useful in treatment of neutrophil dominated inflammatory diseases resulting from neutrophilic infiltration and/or diseases associated with altered cellular functionality of neutrophils, to intermediates for their preparation, to the methods for their preparation, to their use as therapeutic agents, and to salts thereof. | 02-17-2011 |
Mirjana Curic-Bawden, Brookfield, WI US
Patent application number | Description | Published |
---|---|---|
20150086675 | USE OF LACTIC ACID BACTERIA FOR PREPARING FERMENTED FOOD PRODUCTS WITH INCREASED NATURAL SWEETNESS - The dairy industry today faces a problem of providing an alternative to adding sweeteners to fermented milk products in order to achieve the desired sweet taste without the added calories. Furthermore, it would be highly advantageous to establish a method for reducing lactose in fermented milk products to a level which is acceptable for lactose-intolerant consumers. The above problems have been solved by providing mutant | 03-26-2015 |
Mirjana Dimitrijev-Dwyer, Queensland AU
Patent application number | Description | Published |
---|---|---|
20150031600 | DESIGNED BIOSURFACTANTS, THEIR MANUFACTURE, PURIFICATION AND USE - The present invention relates to designed polypeptide biosurfactants that may be prepared by recombinant technology in commercially useful amounts and purified by simple non-chromatographic methods. The designed polypeptide biosurfactants comprise at least one stimuli-responsive amino acid residue or at least one glutamine or asparagine residue and may be useful in modulating the stability of a foam, alone or in combination with an α-helical peptide. The designed polypeptide biosurfactant may be useful in the formation and collapse of foams in foods, beverages, pharmaceuticals, personal care products, cosmetics, cleaning products, mineral recovery, bioremediation, oil recovery and laundry products. The designed biosurfactants may also be useful in recombinant production and purification of peptides, polypeptides and proteins. | 01-29-2015 |
Mirjana Gasperlin, Ljubljana SI
Patent application number | Description | Published |
---|---|---|
20110111042 | SELF-MICROEMULSIFYING SYSTEMS INCORPORATED INTO LIQUID CORE MICROCAPSULES - The invention provides a microcapsule having a shell and a liquid core incorporating a self-microemulsifying system or a microemulsion, wherein the core comprises a lipophilic substance, at least one surfactant, an active agent, a gelling agent and optionally a cosolvent. Furthermore, a method for producing such microcapsules and pharmaceutical formulations comprising such microcapsules is provided. | 05-12-2011 |
Mirjana Gelo-Pujic, Serezin Du Rhone FR
Patent application number | Description | Published |
---|---|---|
20090215881 | Polyphenolic Bioprecursors - Cosmetic and therapeutic, in particular dermatological bioprecursors have the formula [A] | 08-27-2009 |
Mirjana Grujic, Hagersten SE
Patent application number | Description | Published |
---|---|---|
20110293704 | PRIMING OF AN IMMUNE RESPONSE - The present invention relates to a technology and method of priming of an immune response using invariant chain linked antigen, when these are used to prime a subsequent booster immunization using any suitable vacci. | 12-01-2011 |
Mirjana Grujic, Hagersten SI
Patent application number | Description | Published |
---|---|---|
20150056227 | PRIMING OF AN IMMUNE RESPONSE - The present invention relates to a technology and method of priming of an immune response using invariant chain linked antigen, when these are used to prime a subsequent booster immunization using any suitable vacci. | 02-26-2015 |
Mirjana Maletic-Savatic, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20090247860 | SPECTRAL BIOMARKER AND ALGORITHM FOR THE IDENTIFICATION AND DETECTION OF NEURAL STEM AND PROGENITOR CELLS AND THEIR USE IN STUDYING MAMMALIAN BRAINS - The disclosure provides a biomarker and algorithm for identifying and detecting neural stem and progenitor cells and their use in studying mammalian brains. The disclosure further provides magnetic resonance spectroscopy methods and an image enhancing algorithm for the study of the proliferation of these cells and the associated neurogenesis in the live mammalian brain. | 10-01-2009 |
Mirjana Popovic-Lavrinsek, Ottawa CA
Patent application number | Description | Published |
---|---|---|
20140049596 | Localization Algorithm for Conferencing - A conferencing device and method of talker localization for steering a plurality of sensors arranged in sectors around a housing to a current active direction beam. A beamformer is implemented for determining a loudest sector based on signals from the sensors. In the event the loudest sector persists for a first duration then forming signal beams from sensor signals in the loudest sector and a plurality of adjacent sectors over a further duration to create respective signal beam envelopes. Then selecting a highest energy of the beam envelopes to be a loudest non-active beam and comparing the loudest non-active beam to the current active direction beam. If the highest energy one of the beams is greater than the energy of the current active direction beam by a threshold, then selecting the highest energy one of the beams to be the current active direction beam and directing the sensors thereto. | 02-20-2014 |
Mirjana Rajilic-Stojanovic, Beograd RS
Patent application number | Description | Published |
---|---|---|
20120238468 | METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME - The present invention discloses a method for diagnosing Irritable Bowel Syndrome (IBS) in a test sample by determining the level of several bacterial taxa in the test sample, comparing this level with the levels of those bacterial taxa in a control sample, and relating the level to a diagnosis of IBS. Additionally, the present invention provides a method for treatment of IBS based on said diagnosis. Also, the invention provides a method for subtyping IBS in a test sample. | 09-20-2012 |
Mirjana Tosic, Lausanne CH
Patent application number | Description | Published |
---|---|---|
20090297494 | Diagnostic and treatment of a mental disorder - The present invention generally relates to the field of neurological, physiological and psychotic dysfunctions associated with a mental disorder such as schizophrenia, or a predisposition therefor. The invention further relates to genes and proteins, which, when varied in their normal expression, their nucleic acid sequence or in their activity, are associated with the mental disorder. Accordingly, the present invention relates to methods for diagnosis and to methods for prevention and/or treatment of a mental disorder. The present invention additionally relates to compositions for use in diagnosis and to kits for diagnosis of a mental disorder. The invention also relates to the use of a protein or polynucleotide for the manufacture of a medicament for use in the treatment and/or prevention and to a pharmaceutical composition for use in prevention and/or treatment of a mental disorder. Further, the invention relates to methods for screening for a modulator of a mental disorder. More particularly, the present invention relates to methods, compositions and kits, a microarray and reagents for determining the presence of at least one polymorphism and/or at least one combination of polymorphisms of at least one copy of a gene involved in regulating the intracellular glutathione (GSH) level and/or GSH-oxidative stress-related gene expression in a human being. Further, the invention relates to a pharmaceutical composition for use in the treatment and/or prevention of a mental disorder, to the use of an active ingredient such as a protein or polynucleotide for the manufacture of a medicament for use in the treatment and/or prevention of a mental disorder in patients with specific polymorphisms in genes involved in regulating the intracellular GSH level and/or GSH-oxidative stress-related gene expression. The invention also relates to methods of preventing and/or treating a mental disorder comprising administering a medicament to patients having said polymorphisms and to methods of screening for a modulator of a mental disorder. | 12-03-2009 |